Skip to product information
1 of 2

LII LAB

Estimated delivery by 3 months.

PICOSITO 30s ~Metabolic Blend for PCOS

Picosito is a clinically backed blend designed to improve insulin resistance, regulate the menstrual cycle, and support fertility.

PICOSITO combines:

  • The gold-standard inositol ratio for optimal efficacy
  • Clinically supported nutrients for hormonal and metabolic balance
  • A clean, purposeful formulation with no unnecessary additives

30 sachets/box: 1 month supply

Special 50% offer for pre-order customers

Quantity
View full details

Collapsible content

INGREDIENTS

Inositol 2255mg

  • Improve insulin resistance
  • Weight management
  • support fertility 
  • DOWNREGULATES androgen

VITAMIN D 1000IU

  • Hormonal Balance & Ovulation
  • Reduced Symptoms
  • Metabolic Support
  • Anti-Inflammatory Action

Inulin (PREBIOTIC) 1600mg

  • Regulate gut dysbiosis
  • Maintain a healthy glucose level
  • Clean INGREDIENTS as the formula base

Folic Acid 400mcg 

  • support fertility
  • Prevent neural tube defects

USAGE & DIRECTION

  1. Can be consumed directly from the sachet
  2. Can mix with 150ml of warm water

Recommended to be taken once daily. DON’T MIX WITH HOT WATER.

We recommend taking PICOSITO for 3 to 6 months for optimal results.

  • The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial

    Read More 
  • The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review

    Read More 
  • Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies

    Read More 
  • The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone

    Read More 
  • The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria

    Read More 
  • A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women

    Read More 
  • The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients

    Read More 
  • The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios

    Read More 
  • Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports

    Read More